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Brief Summary: Cardiac rehabilitation had an important role in the management of heart failure. 
The predictors of exercise capacity improvement after cardiac rehabilitation are required in the 
management of heart failure. We demonstrated that patients with higher right ventricular strain 
during preload augmentation seem to have a benefit more from cardiac rehabilitation. The simple, 
but novel application of preload stress echocardiography is a noninvasive technique that can be 
used to find a beneficial group with cardiac rehabilitation. 
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Background: It has been recognized that a comprehensive cardiac rehabilitation (CR) program 
improves mortality in patients with chronic heart failure (HF). On the other hand, the magnitude 
of the improvement in exercise capacity after CR differs among individuals. The aim of this 
study was to assess the echocardiographic determinants of responders to CR using preload stress 
echocardiography. 
Methods: We prospectively enrolled 58 chronic HF patients with reduced left ventricular 
ejection fraction (LVEF) (age 62±11 years; 69% male; LVEF 43±7 %) who had received 
optimized medical treatment in a CR program for 5 months. We performed preload 
echocardiographic studies using leg positive pressure (LPP) to assess the echocardiographic 
parameters during preload augmentation. We defined 41 patients as a development cohort to 
assess the predictive value of echocardiographic variables. Next, we validated results in the 
remaining 17 patients as a validation cohort. 
Results: In the development cohort, significant improvement in peak VO2 (>10%) after CR was 
observed in 58% patients. In a multivariable logistic regression model, the significant predictor 
of improvement in exercise capacity was right ventricular (RV) strain during LPP (odds ratio: 
3.96 per 1 SD; p =0.01). A RV strain value of –16% during LPP had good sensitivity of 0.79 and 
specificity of 0.71 to identify patients with improvement in peak VO2. In the validation cohort, 
an optimal cut off value of RV strain value was the same (AUC: 0.77, sensitivity: 0.78, 
specificity: 0.65). 
Conclusion: RV strain during LPP may be an echocardiographic parameter for assessing 
beneficial effects of CR.  
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It has been recognized that a comprehensive cardiac rehabilitation (CR) program improves 
mortality in addition to functional cardiac capacity and symptoms in patients with chronic heart 
failure (HF).1-4 On the other hand, previous reports showed that there were some patients with a 
lack of beneficial effect in exercise capacity after CR, and the lack of effect is an independent 
predictor of adverse cardiovascular events in the future.5-8 The magnitude of the improvement in 
exercise capacity after CR may differ among individuals. Thus, the predictors of responders to 
CR are required in the management of chronic HF patients. 
The determinants of exercise capacity improvement have not been well documented. In a 
previous study, patients with HF reduced ejection fraction who were able to increase cardiac 
output during an initial exercise test showed a significant improvement in exercise capacity with 
training.9 This result suggested that the left ventricular (LV) functional reserve reflects an 
improvement after CR. However, functional reserve was consistent with an increase in both LV 
and right ventricular (RV) contractility.10 Furthermore, RV function has been well established as 
functional and prognostic parameters in several cardiac diseases.11-13 RV function may have an 
important role in improvement after CR. 
Recently, our laboratory developed preload stress echocardiography using leg positive pressure 
(LPP) to assess echocardiographic variables during preload augmentation. In our previous 
studies, cardiac response (changes of stroke volume, E/e’ or LV/RV strains) during preload 
augmentation is an important part of the phenomenon in the evaluation of prognosis and exercise 
capacity in various cardiovascular diseases.14-16 In addition, we showed that impaired RV strain 
during preload augmentation was associated with decreased exercise capacity in chronic HF.17 
Therefore, we hypothesized that RV function during preload augmentation may provide an 
important information to predict responders to CR. This clinical research is planned as a proof of 
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concept study, and the aim of this study was to assess the echocardiographic determinants of 
responders to CR using preload stress echocardiography. 
Methods 
Study population. We prospectively enrolled 58 chronic HF patients who had received 
optimized medical treatment in a CR program for 5 months from October 2013 to October 2017. 
We performed preload echocardiographic studies (detail in the section of stress 
echocardiography) during LPP before the CR program. Cardiopulmonary exercise testing was 
performed to assess the exercise capacity before and after the CR program. To assure relatively 
homogenous study group, all patients fulfilled the following inclusion criteria: 1) HF defined 
according to the European Society of Cardiology guidelines18; 2) reduced LV ejection fraction 
(EF) (≤50%); 3) sinus rhythm; 4) stable clinical condition at the time of echocardiography with 
optimal medical treatment; 5) absence of chronic lung disease; 6) absence of unstable angina; 7) 
absence of severe valvular disease; 8) absence of anemia; 9) completion of CR; and 10) 
technically adequate 2-dimensional and Doppler echocardiograms. We have used the 
development cohort to determine the predictor of responder to CR. Next, we validated the 
predictor in the validation cohort. Because of the necessity of large number of development 
cohort, we defined 41 consecutive patients from October 2013 to September 2016 as a 
development cohort to assess predictors of improvement in peak VO2 and to determine optimal 
cut-off value of echo variables. Next, we validated outcomes in 17 consecutive patients from 
October 2016 to October 2017 as a validation cohort. The Institutional Review Board of the 
Tokushima University Hospital approved the study protocol, and written informed consent was 
obtained from all subjects. 
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Standard echocardiography. Echocardiography was performed using a commercially available 
ultrasound machine (iE33; Philips Healthcare, Amsterdam, The Netherlands; Vivid E9; and GE 
Healthcare, Waukesha, WI). All echocardiographic measurements were obtained according to 
American Society of Echocardiography recommendations.19 Peak systolic longitudinal strain 
(LS) measurements were obtained from gray-scale images recorded in the apical 4-chamber, 2-
chamber, and long-axis views. The frame rate was maintained at a level >40 frame/s. LV strain 
was analyzed offline using speckle tracking vendor-independent software (EchoInsight, Epsilon 
Imaging, Ann Arbor, MI). Global LS (GLS) was obtained by averaging all segmental strain 
values from the apical 4-chamber, 2-chamber, and long-axis views. Peak strain for the 3 right 
ventricular (RV) free wall segments was averaged to produce global RV longitudinal free wall 
strain, with exclusion of the interventricular septum to avoid LV interaction (Figure 1). These 
offline analyses were independently performed in a blinded manner by 2 observers who were not 
involved in the image acquisition and had no knowledge of examination dates and other 
echocardiographic or clinical data. 
Stress echocardiography. All patients underwent preload stress echocardiography. The LPP 
maneuver is useful for pre-load stress echocardiography because it allows noninvasive pre-load 
augmentation during an echocardiographic examination (Supplement 1). We customized a 
commercially available leg massage machine (Dr. Medomer DM5000EX, Medo Industries Co., 
Ltd., Tokyo, Japan) and used a setting of 90 mm Hg, because this pressure did not significantly 
increase either heart rate or systolic blood pressure, based on findings from our studies.14, 15 All 
echocardiographic variables were obtained at baseline and during LPP. All patients tolerated 90 
mm Hg LPP without any complications. 
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Exercise training program. The exercise training program was supervised by a nurse and/or a 
physiotherapist specialized in CR based on the guideline of Japanese Circulation Society.20 The 
duration of the CR program is 5 months. All patients were admitted to the hospital in order to 
start the CR program 5 days per week. Each supervised session consisted of warm-up for 5 
minutes, 30 minutes of pedaling on a bicycle ergometer, and calisthenics for 10 minutes followed 
by cooling down for 5 minutes. After hospitalization, patients continued the designed, supervised 
exercise training program 2-3 times a week and home exercise training at least twice a week for 
5 months. Home exercise training included warm-up for 5 minutes, walking for 30-40 minutes, 
and calisthenics for 10 minutes, followed by cooling down for 5 minutes. The exercise intensity 
of the ergometer portion of the supervised session was performed at a watt strength equivalent to 
the work level 1 minute before the anaerobic threshold during the patients’ maximal symptom-
limited cardiopulmonary exercise tests.21 After hospitalization, patients continued to perform the 
supervised exercise training program one to three times per week, as well as home exercise 
training at least twice a week for 5 months. Home exercise training consisted of 5 minutes of 
warm-up, 30-40 minutes of walking, 10 minutes of calisthenics, and 5 minutes of cool-down 
exercises. Cardiopulmonary exercise testing (CPX) is a reliable method of estimation of exercise 
capacity, especially in patients with HF.22 Peak VO2 was measured from a maximal symptom-
limited CPX in all patients before and after the CR programs.21 Exercise testing was performed 
on an upright bicycle ergometer (STB-3200, CATEYE Co. Ltd. Osaka, Japan). The test started 
with 2 min of rest and 2 min of warmup at 10 Watts followed by a 10-Watt ramp. The test ended 
when symptoms of exhaustion were exhibited. VO2, carbon dioxide production, and ventilation 
were measured and calculated by the gas analysis system (CPEX-1, Inter Reha Co. Ltd., Tokyo, 
Japan). We defined peak VO2 as the highest VO2 obtained during and adequately performed 
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test.22 The primary endpoint was a significant improvement of Peak Vo2 after CR (responders to 
CR), defined as improvement of Peak VO2 >10% after CR. 
Statistical analysis. Data are presented as mean±SD if the Kolmogorov–Smirnov test showed a 
normal distribution. Otherwise, the median and interquartile ranges were used. Comparison of 
baseline characteristics between groups was performed using t tests or the Mann–Whitney U test 
for continuous variables as appropriate and χ2 tests for categorical variables. Between-group 
differences before and after CR were examined using an analysis of covariance (ANCOVA) 
adjusted for baseline measures. There is no interaction between baseline measures and group 
(improved or non-improved). Within-group differences before and after CR were examined 
using paired t tests or Wilcoxon signed-rank tests, as appropriate. Linear regression analysis was 
used to evaluate the associations between several variables and change of peak VO2. Logistic 
regression analysis was used to evaluate the associations between several potential variables and 
improvement in peak VO2. Identified variables (p < 0.20 in the univariate model) were 
considered to enter in a stepwise manner into a multivariable logistic regression model. Logistic 
regression was used to calculate. Receiver-operating characteristic (ROC) curve analysis was 
used to identify parameters that were best to predict improvement in peak VO2. In the 
development cohort, the best cutoff value was defined as the upper limit of the CI of the Youden 
index. The DeLong method was used to compare the C-statistic.23 The improvement in 
predictive accuracy was evaluated by calculating the net reclassification improvement using the 
R package PredictABEL. In the validation cohort, this optimal cut-off value was used to validate 
the prediction of improvement in peak VO2. Statistical analysis was performed using standard 
statistical software packages (SPSS software 21.0; SPSS Inc, Chicago, IL, USA, and MedCalc 
Software 17; Mariakerke, Belgium). Statistical significance was defined by p<0.05. 
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Results 
Patient characteristics. In the development cohort, baseline characteristics of the study group are 
presented in Table 1. The patient population consisted of 88% patients with ischemic 
cardiomyopathy. All patients with ischemic cardiomyopathy were completely revascularized. 
There were no difference of exercise capacity and echocardiographic variables between patients 
with stenosis of left coronary artery and patients with stenosis of right coronary artery. No 
patients dropped out of the study or changed the medical therapies due to the worsening of HF 
during the study period. No significant differences were observed with regard to clinical 
background between the development cohort and the validation cohort. 
CPX parameters at baseline and 5 months. Overall, the CR program significantly increased 
peak VO2 from 14.5±4.6 mL/kg/min to 17.3±6.6 mL/kg/min (p <0.01). There were 15 patients 
with New York Heart Association (NYHA) functional class (FC) II and 26 patients with NYHA 
FC III. After CR, there were 34 patients with NYHA FC II and only 7 patients with NYHA FC 
III. Significant improvement in peak VO2 (>10%) after CR was observed in 58% patients 
(responders to CR), and peak VO2 did not significant improve in 42% patients (non-responders 
to CR). There were no differences of clinical backgrounds between responders to CR and non-
responders to CR. In responders to CR, peak exercise was increased and VE-VCO2 slope was 
decreased significantly after CR. On the other hand, in non-responders to CR, there is no 
significant difference of CPX parameters between at baseline and after CR (Table 2). 
Echocardiographic parameters at baseline and during preload augmentation. 
Echocardiographic data before LPP and during LPP are shown in Table 1. In this cohort, LVEF 
(43±7 %) and LVGLS (-14±5 %) were reduced. Measures of RV function were also below 
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normal reference values. Before LPP, responders to CR had significantly higher SVi, higher 
RVFAC, higher TAPSE, and higher RV free wall strain profiles than non-responders to CR. 
During LPP, responders to CR also had more significantly higher SVi (34±9 ml/m2 vs. 25±8 
ml/m2, p =0.004), lower E/e’ (10.9±4.0 vs. 15.0±6.0 %, p =0.011), higher RVFAC (42±12 % vs. 
33±12 %, p =0.03), and higher RV free wall strain (-19±3 % vs. -14±4 %, p <0.001) profiles than 
non-responders to CR. 
Correlates of changes in exercise capacity after CR. Parameters of myocardial systolic and 
diastolic function correlated to improvement in peak VO2. To determine the responders to CR, 
we performed multivariate analysis of the association between clinical/echocardiographic 
variables and responders to CR. The uni- and multivariate analysis for responders to CR was 
presented in Table 3. In stepwise multivariable logistic regression analysis, SVi during LPP 
(odds ratio: 2.42, 95% CI: 1.01-5.88, p =0.04) and RV free wall strain during LPP (odds ratio: 
3.96, 95% CI: 1.31-11.8, p =0.01) were associated with responders to CR. During LPP, the 
relationships between echocardiographic variables and % change of peak VO2 were significant 
(E/e’: r= -0.30, p =0.05, SVi: r = 0.31, p =0.04, and RV free wall strain: r =0.46, p =0.002) 
(Figure 2A-C). 
Results of the ROC curve analysis used to identify the optimal cutoff point for predicting 
responders to CR were shown in Figure 3. ROC analyses revealed that RV free wall strain 
during LPP had significantly better ability to detect the responders to CR compared with the 
other variables. This RV free wall strain during LPP had the highest AUC (0.81; p <0.001) 
among echocardiographic variables. A RV free wall strain value of –16% during LPP had good 
sensitivity of 0.79 and specificity of 0.71 to identify responders to CR. By incorporating RV free 
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wall strain into age, gender, BMI and SVi, net reclassification index (continuous) for the primary 
endpoint was 0.96 (95% CI, 0.42–1.50; p <0.001). 
In the validation cohort, the RV free wall strain during LPP had the highest AUC (0.77; p 
=0.018) among echocardiographic variables. An optimal cut off value of RV free wall strain 
value was the same. A RV free wall strain value of –16% during LPP had good sensitivity of 
0.78 and specificity of 0.65 to identify responders to CR. Therefore, the RV free wall strain 
during preload augmentation was one marker of responders to CR in patients with systolic 
chronic HF among echocardiographic variables. 
Discussion 
The prognosis of HF patients mainly depends on the exercise capacity.24 CR can improve 
exercise capacity, and had an important role in the management of HF. However, not all the 
patients have improvement in exercise capacity after completion of CR. We demonstrated that 
patients with higher RV free wall strain during LPP seem to have a benefit more from CR. RV 
free wall strain during LPP can be a useful echocardiographic parameter for predicting beneficial 
effects of CR. The simple, but novel application of preload stress echocardiography is a 
noninvasive technique that can be used to find a beneficial group from systolic chronic HF with 
CR. 
LV function in the efficacy of CR. As is well known, not all the patients who undergo CR 
achieve an improvement in exercise capability.5-7 The variable clinical effect of CR is due to 
complex physiological mechanism. It was well established that exercise capacity was determined 
by peripheral factors such as skeletal muscle function, muscle bulk, and endothelial vasodilatory 
capacity rather than the cardiac factors.25 On the other hand, the determinants of an improvement 
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in exercise capacity after CR have not been fully explained. Increased age, severity of disease, 
and poor cardiac function might be expected to influence the ability to benefit from CR. Several 
investigators showed that LV systolic function at rest was not significantly associated with the 
improvement in exercise capacity after CR.26, 27 The resting echocardiographic parameters are 
limited to predict the effectiveness in CR. In a previous study, patients with HF who were able to 
increase cardiac output during an initial exercise test showed a significant improvement in 
exercise capacity with exercise training.9 According to these results, we thought that patients 
with a greater LV functional reserve appear to have the greater potential for improving exercise 
capacity with training. In our study, the stroke volume index during preload augmentation was 
also associated with the improvement in peak VO2. The results of this study are consistent with 
the previous work linking cardiac output during stress with the improvement of exercise capacity 
in HF. Thus, the level of cardiac output during stress was a good predictor of exercise capacity 
after CR in patients with HF. 
RV function in the Efficacy of CR. There is an increasing recognition of the prognostic 
information provided by RV function in cardiovascular disorders such as HF. However, there is 
no knowledge about the relationship between RV function and improvement in exercise capacity 
after CR. In the present study, RV function during preload augmentation was a predictor of 
improvement in peak VO2 after CR. Interestingly, conventional measures of RV function 
(RVFAC and TAPSE) were not significant predictors. The RV free wall strain had the highest 
AUC among echocardiographic variables. In addition, our laboratory also showed that the RV 
function during preload augmentation was associated with exercise capacity in systolic chronic 
HF.17 The results of this study are consistent with our previous work linking RV strain with 
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exercise capacity. RV strain has a good reproducibility and it may be more sensitive than 
conventional measurements in the presence of heart failure. 
The cause of RV dysfunction during pre-load augmentation in patients without 
improvement of exercise capacity is not fully explained given the complex interaction between 
left and right sides of the heart. In normal subjects, responses to pre-load augmentation is an 
increase in SV according to Frank-Starling’s law.28 If there is a sub-clinical RV failure in 
patients, the RV systolic function could not appropriately increase during pre-load augmentation 
according to RV Frank-Starling’s law. Therefore, a lack of improvement in exercise capacity 
occurs in patients with impaired RV strain during preload augmentation due to the sub-clinical 
myocardial dysfunction. Importantly, the LV and RV are connected in series and may influence 
one another in parallel. This ventricular interaction may explain the strong association between 
LV/RV functional reserve and improvement of exercise capacity after CR. In the assessment of 
efficacy after CR, speckle tracking imaging can be used for detailed RV analysis during pre-load 
augmentation. 
Limitations. The sample size was relatively small, and the study population was relatively 
heterogeneous. We could not enter some clinical variables (e.g., weight of skeletal muscle) into 
the model because of the relatively small number of outcomes, which poses a potential risk of 
model overfit. All patients completed CR, and no patient had severe frailty in our cohort. Thus, 
the impact of individual motivation and skeletal muscle volume seem to be small. However, 
exercise capacity is influenced by some unadjusted physiological parameters such as respiratory 
factors.29-31 Although we used a setting of 90 mmHg LPP based on findings from our previous 
studies, we could not completely excluded some metaboreflex activation in this cohort. There are 
physiological differences with another type of stress echocardiography (e.g., supine bicycle or 
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treadmill test). These findings may not be interchangeable with another stress protocol type. In 
our study based on the guideline in Japan, the result may not be directly exploited to the other 
country.20 According to these limitations, the present study should be considered as a proof of 
concept, and we believe that larger prospective multicenter studies are warranted. 
Conclusions. The magnitude of the improvement in exercise capacity after CR differs among 
individuals. Some reports showed that a lack of beneficial effect in exercise capacity after CR is 
the independent predictor of adverse cardiovascular events in the future. Thus, the predictors of 
the improvement in exercise capacity after CR are required in the management of chronic HF 
patients. To the best of our knowledge, this is the first investigation of RV function during 
preload augmentation to predict the responders to CR in systolic chronic HF. RV assessment 
during preload augmentation may have an important role to manage chronic systolic HF. 
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Figure legends: 
Figure 1: Representative Recordings of Doppler and B-mode Echocardiography at Baseline and 
during Leg Positive Pressure (LPP). 
Figure 2: Correlations between Change of peak VO2 and Echocardiographic Variables. 
Figure 3: ROC Curve Analysis of Echocardiographic Variables for Predicting Improvement in 
VO2 before (A) or during (B) Pre-Load Augmentation. The RV free wall strain during LPP had 
the highest AUC (AUC: 0.81) among echocardiographic variables. AUC = area under the curve; 
ROC = receiver-operating characteristic. 
 
Video legend: The leg positive pressure (LPP) maneuver is useful for pre-load stress 
echocardiography because it allows noninvasive pre-load augmentation during an 
echocardiographic examination. LPP stress echocardiography was performed 20 seconds after 
the inflation of the airbags. If the data acquisition time was over 3 minutes, airbags were 
temporarily deflated and then inflated for the analysis. 
Figure 1: A case without improvement of Peak VO2 （63 y.o. female)
Pre LPP
Pre LPP
Transmitral flow
(E/e’: pre: 11, LPP: 14.5)
Left ventricular outflow
(SVi: pre: 40 ml/m2, LPP: 38 ml/m2)
Figure 1: A case without improvement of Peak VO2 （63 y.o. female)
Pre LPP
LPPPre
Tricuspid regurgitant velocity
(PASP: pre: 28 mmHg, LPP: 36 mmHg)
Strain imaging analysis
(RV free wall strain: 16 %, LPP: 14 %)
Figure 2A: Correlation between change of peak VO2 and E/e’
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Figure 2B: Correlation between change of peak VO2 and SVi
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Figure 2C: Correlation between change of peak VO2 and RV free wall strain
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Figure 3: ROC curves
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Table 1: Clinical characteristics 
All Responders to CR 
Non-responders 
to CR p value 
N, % 41 24 (58) 17 (42) 
Age 62±11 63±10 61±13 0.56 
Male, % 28 (68) 18 (75) 10 (59) 0.28 
HR, bpm 76±19 74±13 80±27 0.28 
SBP, mmHg 116±18 117±15 115±21 0.7 
DBP, mmHg 69±17 70±17 67±17 0.57 
Body mass index, kg/m2 24 (23-28) 23 (22-25) 24 (23-28) 0.09 
Diabetes, % 9 (22) 3 (13) 6 (35) 0.09 
Hypertension, % 31 (76) 16 (67) 15 (88) 0.12 
Etiology 
  Ischemic cardiomyopathy, % 36 (88) 22 (92) 14 (82) 0.38 
Drugs 
  ACEI/ARB, % 39 (95) 22 (92) 17 (100) 0.22 
  β-blocker, % 24 (59) 16 (67) 8 (47) 0.23 
  Loop diuretics, % 18 (44) 11 (46) 7 (41) 0.77 
CPX 
  Peak exercise, Watt 96±37 98±37 94±38 0.74 
  HR at peak exercise, bpm 129±30 127±37 131±18 0.69 
  SBP at peak exercise, mmHg 160±30 159±27 163±35 0.66 
  Peak VO2, ml/kg/min 14.5±4.6 14.8±5.4 14.1±3.3 0.67 
  ΔVO2/ΔWR, mL/min/W 6.8±2.7 7.2±2.8 5.8±2.3 0.17 
  VE-VCO2 slope 33±7 33±7 32±8 0.76 
Echocardiography 
Before LPP 
  LVEDVi, ml/m2 65±28 70±28 58±27 0.17 
  LVEF, % 43±7 45±8 40±5 0.21 
  SVi, ml/m2 27±8 30±7 23±8 0.002 
  LVGLS, % -14±5 -14±6 -13±6 0.64 
  E/e' 10.9±4.9 10.5±4.4 11.6±5.6 0.49 
  Peak SPAP, mmHg 32±6 31±5 33±8 0.39 
  RVEDAi, cm2/m2 10±2 9±2 10±3 0.51 
  RVFAC, % 36±14 41±15 30±12 0.015 
  TAPSE, mm 17±5 18±4 15±4 0.022 
  RV free wall strain, % -17±5 -19±4 -15±5 <0.001 
2 
2 
Data are presented as number of patients (percentage), mean ± SD or median (interquartile 
range). 
Abbreviations: HR, heart rate; BP, blood pressure; LVEDVi, left ventricular end-diastolic 
volume index; LVEF, left ventricular ejection fraction; SVi, stoke volume index; E, early 
diastolic transmitral flow velocity; e’, early diastolic mitral annular motion; RVFAC, right 
ventricular functional area change; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid 
annular plane systolic excursion; GLS, global longitudinal strain. 
  LAVi, ml/m2 31±14 29±15 33±13 0.36 
During LPP 
  LVEDVi, ml/m2 69±30 75±26 60±34 0.11 
  LVEF, % 45±7 46±7 44±6 0.69 
  SVi, ml/m2 30±10 34±9 25±8 0.004 
  LVGLS, % -15±4 -16±5 -14±4 0.29 
  E/e' 12.6±5.3 10.9±4.0 15.0±6.0 0.011 
  Peak SPAP, mmHg 36±8 34±7 38±9 0.12 
  RVEDAi, cm2/m2 11±2 11±2 11±2 0.66 
  RVFAC, % 38±13 42±12 33±12 0.03 
  TAPSE, mm 18±3 19±3 17±3 0.09 
  RV free wall strain, % -17±5 -20±3 -14±4 <0.001 
3 
3 
Table 2: CPX parameters at baseline and after CR 
Abbreviations: See Table 1. 
Responders to CR Non-responders to CR 
Baseline After CR Within-group p value Baseline After CR 
Within-group 
p value 
Between-
group p value 
Peak exercise, Watt 98±37 113±42 <0.001 94±38 92±29 0.28 0.04 
Resting HR, bpm 74±11 74±14 0.76 78±13 78±10 0.69 0.41 
Peak HR, bpm 127±37 136±20 0.17 131±18 134±29 0.25 0.42 
Resting BP, mmHg 109±33 102±30 0.15 99±20 90±17 0.08 0.53 
Peak BP, mmHg 159±27 174±23 0.002 163±35 163±30 0.68 0.08 
ΔVO2/ΔWR, mL/min/W 7.2±2.8 7.8±3.3 0.25 5.8±2.3 5.5±2.9 0.26 0.11 
VE-VCO2 slope 33±7 30±7 0.04 32±8 35±14 0.43 0.02 
4 
4 
Table 3: Uni- and multi- variable Associations of responders to CR 
Abbreviations: See Table 1. OR, odds ratio. †Eliminated through the stepwise method. *Odds 
ratio was calculated per increase of 1 SD 
Univariate logistic regression 
analysis 
Stepwise multivariable logistic 
regression analysis 
OR 95% CI p value OR 95% CI p value 
Age 1.02 0.96-1.08 0.14 † 
Male gender 2.10 0.55-7.99 0.28 
Body mass index 0.87 0.74-1.03 0.57 
Diabetes 0.27 0.05-1.25 0.09 † 
Ischemic cardiomyopathy 6.00 1.04-34.7 0.04 † 
CPX variables 
  Peak exercise* 1.18 0.65-2.13 0.59 
  HR at rest* 0.93 0.50-1.74 0.84 
  Systolic BP at rest* 0.98 0.60-1.61 0.96 
  HR at peak* 0.87 0.46-1.67 0.68 
  Systolic BP at peak* 0.86 0.59-1.24 0.39 
  Peak VO2* 1.15 0.60-2.21 0.66 
Echocardiography 
Before LPP 
  LVEF* 1.54 0.79-2.99 0.19 † 
  SVi* 3.18 1.37-7.39 0.01 † 
  LVGLS* 1.17 0.62-2.20 0.64 
  E/e'* 0.79 0.42-1.50 0.48 
  Peak SPAP* 0.76 0.40-1.43 0.39 
  RV free wall strain* 2.40 1.12-5.18 0.03 
During LPP 
  LVEF* 1.14 0.61-2.15 0.68 
  SVi* 3.23 1.43-7.28 0.005 2.42 1.01-5.88 0.04 
  LVGLS* 1.52 0.74-2.73 0.29 
  E/e'* 0.56 0.29-1.10 0.09 † 
  Peak SPAP* 0.59 0.30-1.16 0.13 † 
  RV free wall strain* 4.93 1.72-14.1 0.003 3.96 1.31-11.8 0.01 
